SEC Form SC 13G/A filed by Bright Health Group Inc. (Amendment)

SEC Form SC 13G/A filed by Bright Health Group Inc. (Amendment)

Recent Analyst Ratings for $BHG

$BHG Insider Trading

$BHG Analyst Ratings

$BHG Press Releases

$BHG Large Ownership Changes

$BHG SEC Filings

$BHG Financials

$BHG Leadership Updates

$BHG Market Insights

Recent Analyst Ratings for
$BHG

$BHG
Insider Trading

$BHG
Analyst Ratings

$BHG
Press Releases

$BHG
Large Ownership Changes

$BHG
SEC Filings

$BHG
Financials

$BHG
Leadership Updates

$BHG
Market Insights

Chat with this insight

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4 filed by Yang Rick

SEC Form 4 filed by Walker Paul Edward

SEC Form 4 filed by Sandell Scott D

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Bright Health Group downgraded by JP Morgan

Bright Health Group downgraded by JP Morgan

Bright Health Gr downgraded by RBC Capital with a new price target

Fastest customizable press release news feed in the world

This live feed shows all institutional transactions in real time.

Live finance-specific insights

Live Leadership Updates

Bright Health Group Adopts NeueHealth as Corporate Brand Name

Bright Health Group Closes the Sale of its California Medicare Advantage Business to Molina Healthcare

Bright Health Group Strengthens Capital Position with Amendment to its Credit Facility, Impending Close of the Sale of its California Medicare Advantage Business

SEC Form SC 13G/A filed by Bright Health Group Inc. (Amendment)

SEC Form SC 13D/A filed by Bright Health Group Inc. (Amendment)

SEC Form SC 13D/A filed by Bright Health Group Inc. (Amendment)

Bright Health Group Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

Bright Health Group Inc. filed SEC Form 8-K: Financial Statements and Exhibits

Bright Health Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits

Bright Health Group Reports Third Quarter 2023 Results

Bright Health Group to Host Third Quarter 2023 Earnings Conference Call on November 7, 2023

Bright Health Group Reports Second Quarter 2023 Results

Bright Health Group Appoints Jay Matushak as Chief Financial Officer

Bright Health Group Announces Retirement of General Counsel Keith Nelsen

Bright Health Group Names Leading Healthcare Expert to Board

Live Market Insights

Bright Health Group Adopts NeueHealth As Corporate Brand Name; Company's Common Stock Will Begin Trading Under The New Ticker Symbol "NEUE" On The New York Stock Exchange, Effective January 29, 2024

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session

12 Health Care Stocks Moving In Thursday's Intraday Session

2/14/24 5:04:52 PM ET

$BHG

Medical Specialities

Health Care

Get the next $BHG alert in real time by email

SC 13G/A 1 d791741dsc13ga.htm SC 13G/A SC 13G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)*

NeueHealth, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

10920V 40

(CUSIP Number)

December 31, 2023

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 10920V107		SHCHEDULE 13G		Page 2 of 21 Pages


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	SOLE VOTING POWER 448,648
	6.	SHARED VOTING POWER 0
	7.	SOLE DISPOSITIVE POWER 448,648
	8.	SHARED DISPOSITIVE POWER 0

(1)	The percentage of shares beneficially owned as set forth in row 11 above is based on a total of 7,982,087 shares of Common Stock as of November 2, 2023, as reported by the Issuer in its Form 10-Q filed with the SEC on November 9, 2023.


CUSIP No. 10920V107		SHCHEDULE 13G		Page 3 of 21 Pages


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	SOLE VOTING POWER 359,437
	6.	SHARED VOTING POWER 0
	7.	SOLE DISPOSITIVE POWER 359,437
	8.	SHARED DISPOSITIVE POWER 0


CUSIP No. 10920V107		SHCHEDULE 13G		Page 4 of 21 Pages


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	SOLE VOTING POWER 999.086 (2)
	6.	SHARED VOTING POWER 0
	7.	SOLE DISPOSITIVE POWER 808,085
	8.	SHARED DISPOSITIVE POWER 0

(2)

Pursuant to a proxy arrangement between Deer X L.P. and Deer IX L.P., Deer IX L.P., its general partner Deer IX Ltd., and the directors of Deer IX Ltd. make voting decisions with respect to the 191,001 shares of the Issuer held in the aggregate by Bessemer Venture Partners Century Fund L.P. and Bessemer Venture Partners Century Institutional L.P.


CUSIP No. 10920V107		SHCHEDULE 13G		Page 5 of 21 Pages


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	SOLE VOTING POWER 999,086 (2)
	6.	SHARED VOTING POWER 0
	7.	SOLE DISPOSITIVE POWER 808,085
	8.	SHARED DISPOSITIVE POWER 0


CUSIP No. 10920V107		SHCHEDULE 13G		Page 6 of 21 Pages


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	SOLE VOTING POWER 26,129
	6.	SHARED VOTING POWER 0
	7.	SOLE DISPOSITIVE POWER 26,129
	8.	SHARED DISPOSITIVE POWER 0


CUSIP No. 10920V107		SHCHEDULE 13G		Page 7 of 21 Pages


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	SOLE VOTING POWER 164,872
	6.	SHARED VOTING POWER 0
	7.	SOLE DISPOSITIVE POWER 164,872
	8.	SHARED DISPOSITIVE POWER 0


CUSIP No. 10920V107		SHCHEDULE 13G		Page 8 of 21 Pages


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	SOLE VOTING POWER 0 (2)
	6.	SHARED VOTING POWER 0
	7.	SOLE DISPOSITIVE POWER 191,001
	8.	SHARED DISPOSITIVE POWER 0


CUSIP No. 10920V107		SHCHEDULE 13G		Page 9 of 21 Pages


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	SOLE VOTING POWER 0 (2)
	6.	SHARED VOTING POWER 0
	7.	SOLE DISPOSITIVE POWER 191,001
	8.	SHARED DISPOSITIVE POWER 0


CUSIP No. 10920V107		SHCHEDULE 13G		Page 10 of 21 Pages


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	SOLE VOTING POWER 132
	6.	SHARED VOTING POWER 0
	7.	SOLE DISPOSITIVE POWER 132
	8.	SHARED DISPOSITIVE POWER 0


CUSIP No. 10920V107		SHCHEDULE 13G		Page 11 of 21 Pages


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	SOLE VOTING POWER 132
	6.	SHARED VOTING POWER 0
	7.	SOLE DISPOSITIVE POWER 132
	8.	SHARED DISPOSITIVE POWER 0


CUSIP No. 10920V107		SHCHEDULE 13G		Page 12 of 21 Pages


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	SOLE VOTING POWER 132
	6.	SHARED VOTING POWER 0
	7.	SOLE DISPOSITIVE POWER 132
	8.	SHARED DISPOSITIVE POWER 0


CUSIP No. 10920V107		SHCHEDULE 13G		Page 13 of 21 Pages


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	5.	SOLE VOTING POWER 132
	6.	SHARED VOTING POWER 0
	7.	SOLE DISPOSITIVE POWER 132
	8.	SHARED DISPOSITIVE POWER 0


CUSIP No. 10920V107		SHCHEDULE 13G		Page 14 of 21 Pages

Item 1.

Issuer

(a) Name of Issuer:

NeueHealth, Inc. f/k/a Bright Health Group, Inc. (the “Issuer”)

(b) Address of Issuer’s Principal Executive Offices:

9250 NW 36th St Suite 420

Doral, FL 33178

Item 2(a).

Name of Person Filing:

This statement is being filed by the following persons with respect to certain shares of Common Stock (the “Shares” or the “Common Stock”) of the Issuer. Bessemer Venture Partners IX L.P. (“Bessemer IX”), Bessemer Venture Partners IX Institutional L.P. (“Bessemer Institutional”, and together with Bessemer IX, the “Bessemer IX Funds”), Bessemer Venture Partners Century Fund L.P. (“Bessemer Century”), Bessemer Venture Partners Century Fund Institutional L.P. (“Bessemer Century Institutional”, and together with Bessemer Century, the “Bessemer Century Funds”) and 15 Angels II LLC (“15 Angels”) directly own shares of Common Stock.

(a)	Deer IX & Co. Ltd. (“Deer IX Ltd”), the general partner of Deer IX & Co. L.P. (“Deer IX LP”);

(b)	Deer IX LP, the sole general partner of each of the Bessemer IX Funds;

(c)	Bessemer IX, which directly owns 448,648 Shares;

(d)	Bessemer Institutional which directly owns 359,437 Shares;

(e)	Deer X & Co. Ltd. (“Deer X Ltd”), the general partner of Deer X & Co. L.P. (“Deer X LP”);

(f)	Deer X LP, the sole general partner of the Bessemer Century Funds;

(g)	Bessemer Century, which directly owns 26,129 Shares;

(h)	Bessemer Century Institutional, which directly owns 164,872 Shares;

(i)	Deer VIII & Co. Ltd. (“Deer VIII Ltd”), the general partner of Deer VIII & Co. L.P. (“Deer VIII LP”);

(j)	Deer VIII LP, the sole general partner of Bessemer Venture Partners VIII Institutional L.P. (“Bessemer VIII Institutional”);

(k)	Bessemer VIII Institutional, the sole member of 15 Angels; and

(l)	15 Angels, which directly owns 132 Shares.

Deer IX Ltd, Deer IX LP, Deer X Ltd, Deer X LP, Deer VIII Ltd, Deer VIII LP, Bessemer IX, Bessemer Institutional, Bessemer Century, Bessemer Century Institutional, Bessemer VIII Institutional and 15 Angels are sometimes individually referred to herein as a “Reporting Person” and collectively as the “Reporting Persons.”

Item 2(b).

Address of Principal Business Office or, if None, Residence:

The address of the principal business office of each of the Reporting Persons:

c/o Bessemer Venture Partners

1865 Palmer Avenue; Suite 104

Larchmont, NY 10583


CUSIP No. 10920V107		SHCHEDULE 13G		Page 15 of 21 Pages

Item 2(c).

Citizenship:

Deer IX Ltd— Cayman Islands

Deer IX LP — Cayman Islands

Bessemer IX — Cayman Islands

Bessemer Institutional — Cayman Islands

Deer X Ltd— Cayman Islands

Deer X LP — Cayman Islands

Bessemer Century — Cayman Islands

Bessemer Century Institutional — Cayman Islands

Deer VIII Ltd— Cayman Islands

Deer VIII LP — Cayman Islands

Bessemer VIII Institutional — Cayman Islands

15 Angels — Delaware

Item 2(d).

Title of Class of Securities:

Common Stock, $0.0001 par value

Item 2(e).

CUSIP Number:

10920V 40

Item 3.

Not Applicable.

Item 4.

Ownership.

For Deer IX Ltd:

(a)

Amount beneficially owned: 999,086 Shares

(b)

Percent of class: 12.5%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: –999,086–

(ii)

Shared power to vote or to direct the vote: –0–

(iii)

Sole power to dispose or to direct the disposition of: –808,085–

(iv)

Shared power to dispose or to direct the disposition of: –0–

For Deer IX LP:

(a)

Amount beneficially owned: 999,086 Shares

(b)

Percent of class: 12.5%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: –999,086–

(ii)

Shared power to vote or to direct the vote: –0–

(iii)

Sole power to dispose or to direct the disposition of: –808,085–

(iv)

Shared power to dispose or to direct the disposition of: –0–


CUSIP No. 10920V107		SHCHEDULE 13G		Page 16 of 21 Pages

For Bessemer IX:

(a)

Amount beneficially owned: 448,648 Shares

(b)

Percent of class: 5.6%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: –448,648–

(ii)

Shared power to vote or to direct the vote: –0–

(iii)

Sole power to dispose or to direct the disposition of: –448,648–

(iv)

Shared power to dispose or to direct the disposition of: –0–

For Bessemer Institutional:

(a)

Amount beneficially owned: 359,437 Shares

(b)

Percent of class: 4.5%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: –359,437–

(ii)

Shared power to vote or to direct the vote: –0–

(iii)

Sole power to dispose or to direct the disposition of: –359,437–

(iv)

Shared power to dispose or to direct the disposition of: –0–

For Deer X Ltd:

(a)

Amount beneficially owned: 191,001 Shares

(b)

Percent of class: 2.3%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: –0–

(ii)

Shared power to vote or to direct the vote: –0–

(iii)

Sole power to dispose or to direct the disposition of: –191,001–

(iv)

Shared power to dispose or to direct the disposition of: –0–

For Deer X LP:

(a)

Amount beneficially owned: 191,001 Shares

(b)

Percent of class: 2.3%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: –0–

(ii)

Shared power to vote or to direct the vote: –0–

(iii)

Sole power to dispose or to direct the disposition of: –191,001–

(iv)

Shared power to dispose or to direct the disposition of: –0–


CUSIP No. 10920V107		SHCHEDULE 13G		Page 17 of 21 Pages

For Bessemer Century:

(a)

Amount beneficially owned: 26,129 Shares

(b)

Percent of class: 0.3%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: –26,129–

(ii)

Shared power to vote or to direct the vote: –0–

(iii)

Sole power to dispose or to direct the disposition of: –26,129–

(iv)

Shared power to dispose or to direct the disposition of: –0–

For Bessemer Century Institutional:

(a)

Amount beneficially owned: 164,872 Shares

(b)

Percent of class: 2.0%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: –164,872–

(ii)

Shared power to vote or to direct the vote: –0–

(iii)

Sole power to dispose or to direct the disposition of: –164,872–

(iv)

Shared power to dispose or to direct the disposition of: –0–

For Deer VIII Ltd:

(a)

Amount beneficially owned: 132 Shares

(b)

Percent of class: 0.0%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: –132–

(ii)

Shared power to vote or to direct the vote: –0–

(iii)

Sole power to dispose or to direct the disposition of: –132–

(iv)

Shared power to dispose or to direct the disposition of: –0–

For Deer VIII LP:

(a)

Amount beneficially owned: 132 Shares

(b)

Percent of class: 0.0%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: –132–

(ii)

Shared power to vote or to direct the vote: –0–

(iii)

Sole power to dispose or to direct the disposition of: –132–

(iv)

Shared power to dispose or to direct the disposition of: –0–

For Bessemer VIII Institutional:

(a)

Amount beneficially owned: 132 Shares

(b)

Percent of class: 0.0%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: –132–


CUSIP No. 10920V107		SHCHEDULE 13G		Page 18 of 21 Pages

(ii)

Shared power to vote or to direct the vote: –0–

(iii)

Sole power to dispose or to direct the disposition of: –132–

(iv)

Shared power to dispose or to direct the disposition of: –0–

For 15 Angels:

(a)

Amount beneficially owned: 132 Shares

(b)

Percent of class: 0.0%

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote: –132–

(ii)

Shared power to vote or to direct the vote: –0–

(iii)

Sole power to dispose or to direct the disposition of: –132–

(iv)

Shared power to dispose or to direct the disposition of: –0–

The percentage of shares beneficially owned as set forth above is based on a total of 7,982,087 shares of Common Stock as of November 2, 2023, as reported by the Issuer in its Form 10-Q filed with the SEC on November 9, 2023.

Pursuant to a proxy arrangement between Deer X LP and Deer IX LP, Deer IX LP, its general partner Deer IX Ltd., and the directors of Deer IX Ltd. make voting decisions with respect to the 191,001 shares of the Issuer held in the aggregate by Bessemer Century and Bessemer Century Institutional.

Item 5.

Ownership of Five Percent or Less of a Class.

Not applicable.

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

As the general partner of Deer IX LP, which in turn is the general partner the Bessemer IX Funds, Deer IX Ltd may be deemed to beneficially own 808, 085 Shares held directly by the Bessemer IX Funds and have the power to direct the dividends from or the proceeds of the sale of such Shares. Additionally, pursuant to the proxy arrangement described above, Deer X LP may be deemed to beneficially own 191,001 shares of the Issuer held by Bessemer Century and Bessemer Century Institutional.

As the general partner of Deer X LP, which in turn is the general partner of the Bessemer Century Funds, Deer X Ltd may be deemed to beneficially own 191,001 Shares held directly by the Bessemer Century Funds and have the power to direct the dividends from or the proceeds of the sale of such Shares.

As the general partner of Deer VIII LP, which in turn is the general partner of Bessemer VIII Institutional, which in turn is the sole member of 15 Angels, Deer VIII Ltd may be deemed to beneficially own 132 Shares held directly by 15 Angels and have the power to direct the dividends from or the proceeds of the sale of such Shares.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not applicable.

Item 8.

Identification and Classification of Members of the Group.

Exhibit 2 sets forth information regarding the identity of members of a group. The Reporting Persons disclaim membership in a group and this report shall not be deemed an admission by any of the Reporting Persons that they are or may be members of a “group” for purposes of Rule 13d-5 or for any other purpose.


CUSIP No. 10920V107		SHCHEDULE 13G		Page 19 of 21 Pages

Item 9.

Notice of Dissolution of Group.

Not applicable.

Item 10.

Certification.

Not applicable.


CUSIP No. 10920V107		SHCHEDULE 13G		Page 20 of 21 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 14, 2024



DEER IX & CO. LTD.

By:		/s/ Scott Ring
Name: Scott Ring
Title: General Counsel

DEER IX & CO. L.P.

By:		Deer IX & Co. Ltd, its General Partner

By:		/s/ Scott Ring
		Name: Scott Ring
		Title: General Counsel

BESSEMER VENTURE PARTNERS IX L.P.

BESSEMER VENTURE PARTNERS IX INSTITUTIONAL L.P.

By: Deer IX & Co. L.P., its General Partner

By: Deer IX & Co., Ltd., its General Partner

By:		/s/ Scott Ring
		Name: Scott Ring
		Title: General Counsel

DEER X & CO. LTD.

By:		/s/ Scott Ring
Name: Scott Ring
Title: General Counsel

DEER X & CO. L.P.

By: Deer X & Co. Ltd, its General Partner

By:		/s/ Scott Ring
Name: Scott Ring
Title: General Counsel


CUSIP No. 10920V107		SHCHEDULE 13G		Page 21 of 21 Pages


BESSEMER VENTURE PARTNERS CENTURY FUND L.P.

BESSEMER VENTURE PARTNERS CENTURY FUND INSTITUTIONAL L.P.

By: Deer X & Co. L.P., its General Partner

By: Deer X & Co., Ltd., its General Partner

By:		/s/ Scott Ring
Name: Scott Ring
Title: General Counsel

DEER VIII & CO. LTD.

By:		/s/ Scott Ring
		Name: Scott Ring
		Title: General Counsel

DEER VIII & CO. L.P.

By: Deer VIII & Co. Ltd, its General Partner

By:		/s/ Scott Ring
Name: Scott Ring
Title: General Counsel

BESSEMER VENTURE PARTNERS VIII INSTITUTIONAL L.P.

By: Deer VIII & Co. L.P., its General Partner

By: Deer VIII & Co., Ltd., its General Partner

By:		/s/ Scott Ring
Name: Scott Ring
Title: General Counsel

15 ANGELS II LLC

By:		/s/ Scott Ring
		Name: Scott Ring
		Title: Authorized Person

Get the next $BHG alert in real time by email

Date	Price Target	Rating	Analyst
10/11/2022		Neutral → Underweight	JP Morgan
3/29/2022		Overweight → Neutral	JP Morgan
3/4/2022	$9.00 → $3.00	Outperform → Sector Perform	RBC Capital
3/3/2022	$4.00 → $2.00	Underweight	Morgan Stanley
3/3/2022	$5.00 → $3.50	Neutral	Goldman Sachs
3/3/2022	$5.50 → $4.00	Overweight	Barclays
3/3/2022	$10.00 → $5.00	Overweight	Piper Sandler
3/2/2022		Buy → Underperform	BofA Securities

NAMES OF REPORTING PERSONS

Bessemer Venture Partners IX L.P.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐ (b) ☒

SEC USE ONLY

CITIZENSHIP OR PLACE OF ORGANIZATION

Cayman Islands